GlaxoSmithKline to Pay $3 Billion for Health Fraud
GlaxoSmithKline LLC will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to disclose important safety information.
July 3, 2012 at 12:42 AM
Font size:
Post your comment